From Anti-Neutrophil Cytoplasmic Antibody–Negative to Positive: Eosinophilic Granulomatosis with Polyangiitis Under Benralizumab After Steroid Cessation
Journal of Clinical Practice and Research · 2026 · 87-91
DOI: 10.14744/cpr.2026.74583 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Practice and Research, 2026. Verfasst von Şilan Işık und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, Erciyes University Faculty of Medicine, Kayseri, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Immunology and Allergy, Erciyes University Faculty of Medicine, Kayseri, Türkiye.
Zitieren
APA
Işık, Ş., Yılmaz, İ., Türk, M., Açar, E., & Pektaş Alpsoy, H. (2026). From Anti-Neutrophil Cytoplasmic Antibody–Negative to Positive: Eosinophilic Granulomatosis with Polyangiitis Under Benralizumab After Steroid Cessation. Journal of Clinical Practice and Research, 87-91. https://doi.org/10.14744/cpr.2026.74583
Vancouver
Işık Ş, Yılmaz İ, Türk M, Açar E, Pektaş Alpsoy H. From Anti-Neutrophil Cytoplasmic Antibody–Negative to Positive: Eosinophilic Granulomatosis with Polyangiitis Under Benralizumab After Steroid Cessation. Journal of Clinical Practice and Research. 2026:87-91. doi:10.14744/cpr.2026.74583
BibTeX
@article{Ik2026,
author = {Işık, Şilan and Yılmaz, İnsu and Türk, Murat and Açar, Elif and Pektaş Alpsoy, Hayrunnisa},
title = {From Anti-Neutrophil Cytoplasmic Antibody–Negative to Positive: Eosinophilic Granulomatosis with Polyangiitis Under Benralizumab After Steroid Cessation},
journal = {Journal of Clinical Practice and Research},
year = {2026},
pages = {87--91},
doi = {10.14744/cpr.2026.74583}
}
EUVIMED